methamphetamine and am-356

methamphetamine has been researched along with am-356 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Landa, L; Slais, K; Sulcova, A1
Jurajda, M; Landa, L; Sulcova, A2

Other Studies

3 other study(ies) available for methamphetamine and am-356

ArticleYear
Impact of cannabinoid receptor ligands on behavioural sensitization to antiaggressive methamphetamine effects in the model of mouse agonistic behaviour.
    Neuro endocrinology letters, 2006, Volume: 27, Issue:6

    Topics: Agonistic Behavior; Animals; Arachidonic Acids; Behavior, Animal; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Central Nervous System Stimulants; Drug Administration Schedule; Drug Interactions; Indoles; Ligands; Male; Methamphetamine; Mice; Mice, Inbred ICR; Piperidines; Pyrazoles; Random Allocation; Receptors, Cannabinoid; Statistics, Nonparametric

2006
Altered cannabinoid CB1 receptor mRNA expression in mesencephalon from mice exposed to repeated methamphetamine and methanandamide treatments.
    Neuro endocrinology letters, 2011, Volume: 32, Issue:6

    Topics: Adrenergic Agents; Animals; Arachidonic Acids; Behavior, Animal; Locomotion; Male; Mesencephalon; Methamphetamine; Mice; Neurons; Random Allocation; Receptor, Cannabinoid, CB1; RNA, Messenger

2011
Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide.
    Neuro endocrinology letters, 2012, Volume: 33, Issue:4

    Topics: Animals; Arachidonic Acids; Behavior, Animal; Central Nervous System Sensitization; Dopamine Agents; Drug Administration Schedule; Drug Interactions; Male; Mesencephalon; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Random Allocation; Receptor Cross-Talk; Receptor, Cannabinoid, CB1; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger

2012